HI
MGNX icon

HBK Investments’s MacroGenics MGNX Stock Holding History

HBK Investments’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-194,442
Closed -$3.5M – 881
2019
Q1 		$3.5M Buy
194,442
+171,043
+731% +$2.96M 0.04% 397
2018
Q4 		$297K Sell
23,399
-9,801
-30% -$164K ﹤0.01% 1043
2018
Q3 		$712K Sell
33,200
-10,800
-25% -$230K 0.01% 835
2018
Q2 		$909K Buy
+44,000
New +$991K 0.01% 662
2016
Q4 		– Sell
-9,400
Closed -$281K – 819
2016
Q3 		$281K Buy
+9,400
New +$280K ﹤0.01% 735
2015
Q3 		– Sell
-12,600
Closed -$478K – 1080
2015
Q2 		$478K Sell
12,600
-5,800
-32% -$191K ﹤0.01% 733
2015
Q1 		$577K Buy
+18,400
New +$624K 0.01% 706

Other funds holding MGNX

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

HBK Investments's MGNX Position: Q2 2019 in Review

HBK Investments sold out of MacroGenics (MGNX) in Q2 2019, closing a stake of 194,442 shares — an estimated $3.5M sold.

HBK Investments first reported a position in MGNX in Q1 2015 and held it in 7 quarters. The position peaked at $3.5M in Q1 2019. 130 funds tracked by Wall St. Rank hold MGNX as of Q2 2019.

  • HBK Investments reported no remaining MacroGenics position as of Q2 2019 after selling out during the quarter.
  • HBK Investments sold 194,442 MacroGenics shares in Q2 2019, an estimated $3.5M.
  • HBK Investments first reported a position in MacroGenics in Q1 2015 and held it in 7 quarters.
  • HBK Investments's MacroGenics position peaked at $3.5M in Q1 2019.
  • 130 funds tracked by Wall St. Rank held MacroGenics as of Q2 2019.

Based on HBK Investments's 13F filing for Q2 2019, filed 14 Aug 2019.